BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 27634895)

  • 21. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
    Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
    J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients.
    Ren Y; Yang L; Li M; Wang J; Yan H; Ma N; Liu W; Wang L; Gao X; Gao P; Li T; Liu D
    Sci Rep; 2021 Aug; 11(1):16982. PubMed ID: 34417517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.
    Du WJ; Zhen JH; Zeng ZQ; Zheng ZM; Xu Y; Qin LY; Chen SJ
    Diagn Pathol; 2013 Feb; 8():40. PubMed ID: 23448394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B.
    Zhao Q; Fan YC; Zhao J; Gao S; Zhao ZH; Wang K
    J Viral Hepat; 2013 Jun; 20(6):430-7. PubMed ID: 23647960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma.
    Mo C; Wu J; Sui J; Deng Y; Li M; Cao Z; Hu Z; Huang J; Li S
    Clin Biochem; 2022 Oct; 108():56-62. PubMed ID: 35760369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased GPX3 mRNA level in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma.
    Han LY; Sun WJ; Zhao ZH; Gao S; Wang K
    Trans R Soc Trop Med Hyg; 2023 Oct; 117(10):727-732. PubMed ID: 37310002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
    Tian CH; Dai J; Zhang W; Liu Y; Yang Y
    Medicine (Baltimore); 2019 Jun; 98(23):e15924. PubMed ID: 31169710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma.
    Miao LL; Wang JW; Liu HH; Gao S; Fan YC; Wang K
    Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):35-42. PubMed ID: 36878837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
    Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV.
    Zhao XL; Yang JR; Lin SZ; Ma H; Guo F; Yang RF; Zhang HH; Han JC; Wei L; Pan XB
    Gut; 2016 Mar; 65(3):502-11. PubMed ID: 26045139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
    Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
    Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
    Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.
    Huyen PTM; Dung DTN; Weiß PJ; Hoan PQ; Giang DP; Uyen NT; Van Tuan N; Trung NT; Velavan TP; Song LH; Hoan NX
    Int J Infect Dis; 2022 Feb; 115():229-236. PubMed ID: 34910956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients.
    Hoan NX; Tong HV; Hecht N; Sy BT; Marcinek P; Meyer CG; Song le H; Toan NL; Kurreck J; Kremsner PG; Bock CT; Velavan TP
    EBioMedicine; 2015 Dec; 2(12):2080-6. PubMed ID: 26844288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.
    Hoan NX; Van Tong H; Giang DP; Cuong BK; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Song LH; Velavan TP
    Oncotarget; 2017 Mar; 8(10):17127-17139. PubMed ID: 28179578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection.
    Meng Z; Zhang Y; Wei Z; Liu P; Kang J; Zhang Y; Ma D; Ke C; Chen Y; Luo J; Gong Z
    BMC Gastroenterol; 2017 Jan; 17(1):6. PubMed ID: 28061755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DQA1 & DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis & hepatocellular carcinoma.
    Karra VK; Chowdhury SJ; Ruttala R; Gumma PK; Polipalli SK; Chakravarti A; Kar P
    Indian J Med Res; 2018 Jun; 147(6):573-580. PubMed ID: 30168489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.